Chhattisgarh govt's flagship scheme delivers hefty markdown on medicines

The state government has given priority to the health security of the people, the official said

pharma, medicine, drugs
In the first phase, 192 stores started operating in urban areas
R Krishna Das Raipur
2 min read Last Updated : Nov 03 2022 | 6:58 PM IST

Don't want to miss the best from Business Standard?

Offering discounts of 50-70 per cent on medicines is no normal business in the pharmaceutical sector.
 
But the Chhattisgarh government has made it a policy with another flagship scheme called “Shri Dhanwantri Generic Medical Store Scheme”.
 
Launched in October last year, it provides medicines at affordable rates to people on the basis of the below-the-poverty line card, and is being implemented by the urban development department while a committee headed by the district collector monitors the execution and procurement of medicines in each district.
 

Also Read

A senior official with the department said the people in Chhattisgarh were getting a big relief from expensive medicines because life-saving and other expensive drugs were now available at less than half the cost.
 
Besides, the stores also make available equipment at affordable rates.
 
The state government has given priority to the health security of the people, the official said.
 
In the first phase, 192 stores started operating in urban areas. In Raipur, 19 shops, the highest, are located.
 
After the launch of the scheme, 3.2 million consumers have purchased medicines and saved more than Rs 62 crore, the official said.
 
“As on October 31, the combined maximum retail prices (MRPs) of the medicines purchased by collectors for retail counters and mobile medical units were more than Rs 101 crore while they were provided to people for a little more than Rs 40 crore,” the official said.
 
The urban development department has provided shops to owners for a token rent of Rs 2 per square foot. Under the scheme, the shops have been authorised to give a discount of 50-70 per cent on MRP.
 
The officials said in the next phase of the scheme, the home delivery of medicines would start.
 
Another scheme, providing medical facilities in weekly markets, is evoking a good response. The Mukhyamantri Haat-Bazaar Clinics Scheme is being implemented in remote and inaccessible areas, while in urban areas medical facilities are being provided to people living in slums of urban areas through the Mukhyamantri Slum Health Scheme.
 
In medical camps, there are facilities for free check-ups, consultation, distributing free medicines, and even pathology tests.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :ChhattisgarhMedicinesgeneric medicineshealthcarePharmaceutical companiesChhattisgarh governmentModi flagship schemespharmaceutical firmsPharma sector

Next Story